Both in Medical Labs
Caris Life Sciences vs Celcuity
Over the past year CAI returned +7.2% and CELC returned −10.8%; their daily moves had a correlation of 0.15.
CAI +7.2% CELC −10.8%Growth of $1, one year, split-adjusted
| Metric | CAI | CELC |
|---|---|---|
| Price | $32.10 | $67.07 |
| Market cap | $9.07B | $3.28B |
| Today | −6.50% | −2.98% |
| 1 month | +13.4% | −7.0% |
| 6 months | +71.7% | −53.7% |
| Year to date | +19.0% | −32.8% |
| 1 year | +3.0% | −15.1% |
| Revenue growth (YoY) | +45.4% | — |
| Gross margin | 68.1% | — |
| Net margin | −0.2% | — |
| P/E (TTM) | 86.3× | — |
| Price / sales | 9.2× | — |
| Net cash | $400.0M | $809.0K |
| Dividend yield | — | — |
| Volatility (60d) | 64.9% | 53.2% |
| Short % of float | 12.5% | 25.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).